3Termorshuizen F, Korevaar JC, Dekker FW, et al. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis ( NECOSAD ) -2. Am J Kidney Dis ,2003,41 ( 6 ) : 1293-1302. 被引量：1
4Oreopoulos DG. The optimization of continuous ambulatory peritoneal dialysis. Kidney Int, 1999,55 (3) : 1131-1149. 被引量：1
5Hashimoto Y, Matsubara T. Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients. Adv Perit Dial ,2000,16 : 108-112. 被引量：1
6Davies S J, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephro1,2001,12 : 1046-1051. 被引量：1
7Davies S J, Brown EA, Frandsen NE, et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int,2005,67 (4) :1609-1615. 被引量：1
8Kawanishi H, Hashimoto Y, Nakamoto H, et al. Combination therapy with peritoneal dialysis and hemodialysis. Petit Dial Int, 2006,26(2) :150-154. 被引量：1
9Ota K. Why is PD + HD combination therapy necessary? Touseki Care,2001,7 : 18-19. 被引量：1
10Arizono K, Matsuoka K, Miyamoto T, et al. Examination of the utility for PD + HD combination therapy. Jin to Touseki. 1999,47:65-69. 被引量：1
